Skip to main content
. 2018 Dec 12;4(12):1624–1632. doi: 10.1021/acscentsci.8b00344

Figure 2.

Figure 2

In vitro activation of TCO–Vanco and TCO–Dapto by TAG. (A) HPLC analysis of in vitro activation of TCO–Vanco. A 25 mg portion of TAG was treated with the 5 nmol doses of TCO–Vanco at 0, 24, and 48 h. (B) Cumulative release of vancomycin after mixing TAG with the three doses of TCO–Vanco. (C) LC-MS analysis of in vitro activation of TCO–Dapto. A 25 mg portion of TAG was treated with the 5 nmol doses of TCO–Dapto at 0, 24, and 48 h. (D) Cumulative release of daptomycin after mixing TAG with the three doses of TCO–Dapto.